{"filing":{"accession_number":"0001104659-26-075969","cik":"0001769484","ticker":"BIOX","company_name":"Bioceres Crop Solutions Corp.","form":"6-K","filing_date":"2026-06-22","report_date":null,"primary_document":"tm2618174d1_6k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1769484/000110465926075969/tm2618174d1_6k.htm"},"events":[{"id":12518,"run_id":11095,"accession_number":"0001104659-26-075969","anchor_item_number":"EX-99.1","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"This exhibit is a press release announcing Bioceres' fiscal third quarter 2026 financial results (quarter ended March 31, 2026), including revenues of $39.4 million, net loss of $13.4 million, and Adjusted EBITDA of $(0.6) million. The document explicitly states \"Bioceres Crop Solutions Reports Fiscal Third Quarter 2026 Financial and Operational Results\" and includes detailed financial tables, management commentary, and reconciliations typical of a quarterly earnings release. Material to investors as it discloses significant operating losses and deteriorating financial performance.","company_name":"Bioceres Crop Solutions Corp.","ticker":"BIOX","filing_date":"2026-06-22","form":"6-K","submitted_at":null,"items":[{"id":9392,"accession_number":"0001104659-26-075969","item_number":"EX-99.1","item_title":"tm2618174d1_ex99-1.htm","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This exhibit is a press release announcing Bioceres' fiscal third quarter 2026 financial results (quarter ended March 31, 2026), including revenues of $39.4 million, net loss of $13.4 million, and Adjusted EBITDA of $(0.6) million. The document explicitly states \"Bioceres Crop Solutions Reports Fiscal Third Quarter 2026 Financial and Operational Results\" and includes detailed financial tables, management commentary, and reconciliations typical of a quarterly earnings release. Material to investors as it discloses significant operating losses and deteriorating financial performance.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-06-22T10:08:07.579573+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":9392,"accession_number":"0001104659-26-075969","item_number":"EX-99.1","item_title":"tm2618174d1_ex99-1.htm","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This exhibit is a press release announcing Bioceres' fiscal third quarter 2026 financial results (quarter ended March 31, 2026), including revenues of $39.4 million, net loss of $13.4 million, and Adjusted EBITDA of $(0.6) million. The document explicitly states \"Bioceres Crop Solutions Reports Fiscal Third Quarter 2026 Financial and Operational Results\" and includes detailed financial tables, management commentary, and reconciliations typical of a quarterly earnings release. Material to investors as it discloses significant operating losses and deteriorating financial performance.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-06-22T10:08:07.579573+00:00","company_name":"Bioceres Crop Solutions Corp.","ticker":"BIOX","filing_date":"2026-06-22"}]}